Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

NCT01230957 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
650
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi Pasteur, a Sanofi Company